A clinical extension trial to look at how well and safe ocrelizumab works long-term in people with multiple sclerosis who benefitted from ocrelizumab in a previous F. Hoffmann-La Roche Ltd sponsored trial
This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)
Autoimmune Disorder Multiple Sclerosis (MS)
For the latest version of this information please go to www.forpatients.roche.com